The health ministry is considering strict actions, including immediate license suspensions, for drugmakers producing substandard drugs. Thi...

The Indian Pharmaceutical Alliance (IPA) has proposed reducing the import duty on pharma products from the US to zero. Currently, India imp...

The govt may extend the deadline for drug manufacturers to comply with revised Schedule M standards until December 2025. A final notificati...

The drug regulator had earlier this year formed an expert panel to evaluate medicines which can become OTC from prescription after pharmace...

In a recent diktat, the government said action will be taken against pharma units that are flouting the norms by manufacturing nutraceutica...

"We welcome the UCPMP. It is a balanced order that ensures that there is a healthy and ethical engagement between the pharmaceutical indust...

According to the OPPI, launching a new drug in India is delayed by up to four years, compared to markets like the US and the European Union...

The pharmaceutical industry has sought an exemption from ceiling price for all low-priced formulations up to Rs 5 per unit. In a meeting he...

A high-level committee formed under Niti Aayog's VK Paul held a meeting on Friday with the representatives of pharma lobby groups to review...

"In the meeting as part of stakeholder consultations, the committee has desired to have the view of Organisation of Pharmaceutical Producer...

"Simple waiving of patents for vaccines is not enough for increased and free availability of Vaccines in India,” it said in a statement.The...

India is trying to encourage local manufacture of APIs, intermediates and key starting material used in the production of drugs and cut dep...

The DoP secretary has told both the domestic and multinational pharma lobby groups along with the medical device industry to “strictly” com...

The annual report of Global Intellectual Property Centre, an organisation under the US Chamber of Commerce, has ranked India 43 among 45 co...

Indian Drugs Manufacturing Association will take a call on legal action in its meeting on Friday after a new directive by the health minist...

The competition commission of India has cracked a whip on the Indian drug manufacturers for encouraging unfair trade practises by colluding...

Reliance Industries, Nasscom, Sun Pharma and Orchid Chemicals -- have together paid close to $2,75,000 (about Rs 1.4 crore) towards lobbyin...